ZBI Equities’s Gilead Sciences GILD Stock Holding History

ZBI Equities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-2,347,740	Closed	-$176M	–	8
2013 Q4	$176M	Buy	+2,347,740	New	+$163M	9.54%	3

Other funds holding GILD

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ZBI Equities's GILD Position: Q1 2014 in Review

ZBI Equities sold out of Gilead Sciences (GILD) in Q1 2014, closing a stake of 2,347,740 shares — an estimated $176M sold.

ZBI Equities first reported a position in GILD in Q4 2013 and held it in 1 quarter. The position peaked at $176M in Q4 2013. 1,189 funds tracked by Wall St. Rank hold GILD as of Q1 2014.

ZBI Equities reported no remaining Gilead Sciences position as of Q1 2014 after selling out during the quarter.
ZBI Equities sold 2,347,740 Gilead Sciences shares in Q1 2014, an estimated $176M.
ZBI Equities first reported a position in Gilead Sciences in Q4 2013 and held it in 1 quarter.
ZBI Equities's Gilead Sciences position peaked at $176M in Q4 2013.
1,189 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2014.

Based on ZBI Equities's 13F filing for Q1 2014.